Heart disease, including heart attacks and strokes, remains the leading cause of death in the United States. Despite efforts ...

For patients with a poor prognosis, local thrombolysis with urokinase or recombinant tissue plasminogen activator should be initiated. Ultimately, if the patient is not a good candidate for local or ...

They found that T-cells can be used to fight off another type of cell called the uPAR (urokinase plasminogen activator ...

However, neither of these treatments offers significant fibrinolytic activity, relying instead on the body's own urokinase. Acute DVT refers to symptoms less than 14 days. - ultrasound-assisted ...

Researchers identified several inflammatory circulating proteins that could be useful biomarkers for predicting outcomes in ...

Ovarian cancer is a relatively manageable malignancy when diagnosed at an early stage, but late-stage detection almost always translates into a poor prognosis. Researchers have been vigorously ...

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.